Stable weight during lamotrigine therapy: A review of 32 studies
- 22 February 2000
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 54 (4), 973-975
- https://doi.org/10.1212/wnl.54.4.973
Abstract
Article abstract A side effect associated with the use of some antiepileptic drugs (AEDs) is change in body weight. To evaluate the effect of lamotrigine on body weight in adult patients with epilepsy, we conducted a retrospective review of data from 463 patients treated with lamotrigine in 32 clinical trials. Mean daily dose was 259 (±155) mg and duration of therapy was 318 (±87) days. The mean change in body weight was 0.5 (±5) kg. Lamotrigine was associated with stable body weight in patients with epilepsy.Keywords
This publication has 10 references indexed in Scilit:
- Topiramate - Safety and TolerabilityCanadian Journal of Neurological Sciences, 1998
- Changes in Body Weight With Chronic, High-Dose Gabapentin TherapyTherapeutic Drug Monitoring, 1997
- Weight gain in epileptic patients during treatment with valproic acid: a retrospective study.Canadian Journal of Neurological Sciences, 1997
- Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril®)Seizure, 1997
- Obesity and endocrine disorders in women taking valproate for epilepsyAnnals of Neurology, 1996
- Bodyweight Change as an Adverse Effect of Drug TreatmentDrug Safety, 1996
- Weight Loss in Patients Taking FelbamateClinical Neuropharmacology, 1995
- Medical Hazards of ObesityAnnals of Internal Medicine, 1993
- Weight Gain, Increased Appetite, and Excessive Food Intake Induced by CarbamazepineClinical Neuropharmacology, 1991
- Effects of sodium valproate in 100 children with special reference to weight.BMJ, 1981